Free tool
FAERS Monitor: Calcium Gluconate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 210906 or its brand name (Calcium Gluconate, Calcium Gluconate). Reports on generic versions are filed under their own applications.
Reports
12,181
Serious
10,040
82% of reports
Hospitalization
5,672
Death reported
2,619
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,241
- pain1,748
- fatigue1,724
- off label use1,670
- rheumatoid arthritis1,435
- nausea1,420
- alopecia1,369
- vomiting1,331
- pemphigus1,301
- arthropathy1,290
- abdominal discomfort1,284
- psoriatic arthropathy1,283
- systemic lupus erythematosus1,275
- diarrhoea1,229
- glossodynia1,227
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 223 |
| 2005 | 2,287 |
| 2006 | 1,041 |
| 2007 | 89 |
| 2008 | 283 |
| 2009 | 112 |
| 2010 | 104 |
| 2011 | 124 |
| 2012 | 178 |
| 2013 | 170 |
| 2014 | 163 |
| 2015 | 203 |
| 2016 | 258 |
| 2017 | 335 |
| 2018 | 393 |
| 2019 | 543 |
| 2020 | 688 |
| 2021 | 702 |
| 2022 | 936 |
| 2023 | 900 |
| 2024 | 874 |
| 2025 | 1,059 |
| 2026 | 516 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,978 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pemphigusSignal | 1,301 | 200.4 | 189.8 | 231,281 |
| glossodyniaSignal | 1,227 | 100.1 | 94.7 | 113,781 |
| systemic lupus erythematosusSignal | 1,275 | 64.3 | 61.0 | 76,668 |
| psoriatic arthropathySignal | 1,283 | 56.3 | 53.4 | 67,600 |
| arthropathySignal | 1,290 | 41.0 | 38.9 | 49,262 |
| rheumatoid arthritisSignal | 1,435 | 22.1 | 21.0 | 28,665 |
| abdominal discomfortSignal | 1,284 | 13.3 | 12.6 | 14,612 |
| alopeciaSignal | 1,369 | 12.1 | 11.5 | 13,982 |
| painSignal | 1,748 | 4.9 | 4.7 | 5,612 |
| vomitingSignal | 1,331 | 4.9 | 4.7 | 4,209 |
| fatigueSignal | 1,724 | 3.8 | 3.7 | 3,732 |
| off label useSignal | 1,670 | 3.3 | 3.2 | 2,782 |
| diarrhoeaSignal | 1,229 | 3.3 | 3.1 | 2,017 |
| nauseaSignal | 1,420 | 3.1 | 3.0 | 2,095 |
| drug ineffectiveSignal | 2,241 | 2.9 | 2.8 | 3,052 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.